| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/18/2013 | WO2013104728A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/18/2013 | WO2013104104A1 Breast cancer diagnosis and indication marker |
| 07/18/2013 | WO2013082282A8 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease. |
| 07/18/2013 | WO2013071068A3 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 07/18/2013 | WO2013064701A3 Specific antibodies and their isolation with anti-idiotypic antibodies |
| 07/18/2013 | WO2013042053A3 Compounds for use in the treatment of alzheimer's disease |
| 07/18/2013 | WO2013038191A3 Anti-cd134 (ox40) antibodies and uses thereof |
| 07/18/2013 | WO2013033092A3 Streptococcus suis pilus antigens |
| 07/18/2013 | US20130184441 Detection of Neurodegenerative Disease |
| 07/18/2013 | US20130184440 Super-humanized antibodies |
| 07/18/2013 | US20130184438 Mutant protein |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184210 Variants derived from actriib and uses therefor |
| 07/18/2013 | US20130184185 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 07/18/2013 | US20130183688 Tim-3 ligands and methods thereof |
| 07/18/2013 | US20130183350 Immunogenic compositions |
| 07/18/2013 | US20130183326 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 07/18/2013 | US20130183324 Immunogens for treatment of neoplastic and infectious disease |
| 07/18/2013 | US20130183320 Anti-lrp5 antibodies and methods of use |
| 07/18/2013 | US20130183319 Fgfr4 antibodies |
| 07/18/2013 | US20130183316 Agonistic antibody to cd27 |
| 07/18/2013 | US20130183315 Antibodies that bind to OX40 and their uses |
| 07/18/2013 | US20130183314 High affinity antibodies that neutralize staphylococcus enterotoxin b |
| 07/18/2013 | US20130183313 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/18/2013 | US20130183311 Bispecific binding agents for modulating biological activity |
| 07/18/2013 | US20130183310 Administering anti-placental growth factor antibodies |
| 07/18/2013 | US20130183307 Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
| 07/18/2013 | US20130183306 Anti-cd19 antibody having adcc function with improved glycosylation profile |
| 07/18/2013 | US20130183305 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 07/18/2013 | US20130183299 Anti-folate receptor alpha antibodies and uses thereof |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183293 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue , and/or fever |
| 07/18/2013 | US20130183291 Canine thymic stromal lymphopoietin protein and uses thereof |
| 07/18/2013 | US20130183288 Non-fucosylated antibodies |
| 07/18/2013 | CA2861003A1 Dual antigen-induced bipartite functional complementation |
| 07/18/2013 | CA2860914A1 Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
| 07/17/2013 | EP2615176A1 Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
| 07/17/2013 | EP2615175A1 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals |
| 07/17/2013 | EP2615115A2 Antigen-binding constructs |
| 07/17/2013 | EP2615114A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615113A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615108A1 Modified human plasma polypeptide or fc scaffolds and thier uses |
| 07/17/2013 | EP2614837A1 Anti-VEGF antibody compositions and methods |
| 07/17/2013 | EP2614143A1 Immunotherapy of cancer using genetically engineered gd2-specific t cells |
| 07/17/2013 | EP2614086A1 Methods for assessing and identifying or evolving conditionally active therapeutic proteins |
| 07/17/2013 | EP2614085A2 Anti-il-1 beta antibodies and methods of use |
| 07/17/2013 | EP2614084A2 Anti-human folate receptor beta antibodies and methods of use |
| 07/17/2013 | EP2614083A2 An immunosuppressive drug combination for a stable and long term engraftment |
| 07/17/2013 | EP2614082A1 4-1bb binding molecules |
| 07/17/2013 | EP2614081A1 Anti-vegfr-3 antibody compositions |
| 07/17/2013 | EP2614080A1 Phosphorylated twist1 and metastasis |
| 07/17/2013 | EP2614077A1 Chimeric antigen receptors with an optimized hinge region |
| 07/17/2013 | EP2614072A2 Human cytomegalovirus vaccine |
| 07/17/2013 | EP2613808A1 Companion animal treatments |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/17/2013 | CN1906212B Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 07/17/2013 | CN103209996A Silent fc variants of anti-cd40 antibodies |
| 07/17/2013 | CN103209995A VEGF-binding molecules |
| 07/17/2013 | CN103209994A Antibodies useful in passive influenza immuization |
| 07/17/2013 | CN103209993A Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid |
| 07/17/2013 | CN103209709A Anti-MHC antibody anti-viral cytokine fusion protein |
| 07/17/2013 | CN103205436A Humanized immunoglobulin loci |
| 07/17/2013 | CN103204937A Single-domain heavy chain antibody T10 aiming at immune globulin Fc segment |
| 07/17/2013 | CN103204936A Preparation method for polyclonal antibody to salmonella effect protein SopB |
| 07/17/2013 | CN103204935A Modified Antigen Binding Molecules With Altered Cell Signaling Activity |
| 07/17/2013 | CN103204934A Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44 |
| 07/17/2013 | CN103204933A High-stability human anti-VEGF (vascular endothelial growth factor) antibody and application thereof |
| 07/17/2013 | CN103204932A Preparation method of cyprinus carpio glucose transporter Sglt1 rabbit antiserum |
| 07/17/2013 | CN103204931A Human Monoclonal Antibodies To Fucosyl-gm1 And Methods For Using Anti-fucosyl-GM1 |
| 07/17/2013 | CN103204930A Preparation method for polyclonal antibody of aspergillus fumigatus |
| 07/17/2013 | CN103204929A Preparation method for candida albicans polyclonal antibody |
| 07/17/2013 | CN103204928A Preparation method for polyclonal antibody of cryptococcus neoformans |
| 07/17/2013 | CN103204927A Preparation method for monoclonal antibody of cryptococcus neoformans |
| 07/17/2013 | CN103204926A Monoclonal antibody aiming at H5 avian influenza virus |
| 07/17/2013 | CN103204925A Synthetic method of general artificial antigen of phthalate plasticizers for immunodetection |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN102747043B Hybridoma cell line 3G1 and anti-alfatoxin B1 monoclonal antibody produced by the same |
| 07/17/2013 | CN102584995B Monoclonal antibody resistant to human phosphodiesterase 4D interaction protein variant 5 and application thereof |
| 07/17/2013 | CN102559604B Monoclonal antibody having antagonistic action on HMGB1 B box and application thereof |
| 07/17/2013 | CN102286431B Monoclonal antibody for resisting Japanese encephalitis virus (JEV) and application thereof |
| 07/17/2013 | CN102220288B Mouse-addapted enterovirus EV71 strain 573 and use thereof |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102203286B Determination of immunoglobulin encoding nucleid acid |
| 07/17/2013 | CN101918443B Antigen associated with rheumatoid arthritis |
| 07/17/2013 | CN101903404B Bivalent, bispecific antibodies |
| 07/17/2013 | CN101782579B Enzyme-linked immunoassay kit for detecting tiamulin medicaments, and application thereof |
| 07/17/2013 | CN101754977B Variable tangential flow filtration |
| 07/17/2013 | CN101553505B Antibodies directed to alphaVbeta6 and uses thereof |
| 07/17/2013 | CN101472943B SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/17/2013 | CN101379086B Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 07/17/2013 | CN101360999B Intraocular pressure-regulated early genes and uses thereof |
| 07/17/2013 | CN101331228B Transgenic silkworm capable of producing antibody and method for production thereof |
| 07/17/2013 | CN101184777B Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 07/17/2013 | CN101184506B Methods and compositions for modulating hyperstabilized c-met |
| 07/17/2013 | CN101076730B Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 07/16/2013 | US8487083 Monoclonal antibodies capable of simultaneously binding domains II and IIIc of type 1 fibroblast growth factor receptor |
| 07/16/2013 | US8487082 Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions |
| 07/16/2013 | US8487081 Antibodies specific for human hepcidin |